Donald Trump’s effort to freeze trillions of dollars in federal grants is the most provocative of his many attempts to expand ...

Is the new JetBlue Premier card worth the hype? Let's have a look at the card's welcome bonus, annual fee and benefits — and ...

Yet no opening presidential bid for power compares to President Donald Trump’s out-of-the-blue freeze of federal funds across the government. Much about the initial memo from Matthew Vaeth, the acting ...

Work and Pensions Secretary Liz Kendall confirmed the forecast overspend in a written statement to MPs, adding 'no action' ...

When business leaders are unclear on the future, they tend to pause before making material investments. Pending tariffs are causing a lot of uncertainty for businesses.

House Republicans are leaving their issues retreat in Florida with a lot of big questions still unanswered about their agenda ...

The Chargers improved around the margins last offseason but GM Joe Hortiz will have the money to make a splash in free agency ...

The AI sell-off created panic, but markets often overreact. Check out 2 stocks with strong fundamentals and attractive ...

XHB has outperformed the S&P 500 by 13 percentage points since my last buy rating, with shares up 58%, and I see more upside ...

Lockheed should benefit from recent and foreseeable increases in US defense spending, driven in the short term by orders to resupply munitions expended in Ukraine far faster than they can be made.

The Centers for Medicare and Medicaid Services (CMS) says about 8,247,000 people with Medicare Part D coverage use the ten drugs selected for price negotiation.

Other Republican lawmakers also highlighted the cost of the renewable energy transition. The Climate Leadership and Community Protection Act, which sets a statewide goal of reducing carbon emissions ...